in

Gene therapy company: Applied Genetic Technologies Corporation (AGTC)

Applied Genetic Technologies Corporation (NASDAQ: AGTC) was founded in 1999 and is headquartered in Alachua, Florida, USA, with 78 full-time employees. It is a clinical-stage biotechnology company that develops transformations for patients with rare and debilitating diseases. Gene therapy.

Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation (AGTC):

The main products of Applied Genetic Technologies include four ophthalmology development projects involving three goals, including:

1. X-linked retinoschisis, in phase I/II clinical trials;

2. X-linked retinitis pigmentosa (retinitis pigmentosa), in phase I/II clinical trials;

3. Achromatopsia, a phase I/II clinical trial for the treatment of hereditary retinal diseases, and preclinical procedures for adrenal leukodystrophy, which is a central nervous system and otological disease.

Applied Genetic Technologies Corporation has signed a cooperation agreement with Biogen MA, Inc., 4D Molecular Therapeutics, Synpromics Limited, Bionic Sight, LLC and the University of Florida Research Foundation.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

Canadian Gold Mining Company: Alamos Gold, Inc. (AGI) (2003)

Medical equipment company: Escalon Medical (ESMC) (1987)